Search results for the GEO ID: GSE37645
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM924978
GPL570
Panc265 xenograft GSI_265B Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_265B donor cell line: Panc265 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924979
GPL570
Panc253 xenograft GSI_253B Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_253B donor cell line: Panc253 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924980
GPL570
Panc291 xenograft GSI_291B Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_291B donor cell line: Panc291 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924981
GPL570
Panc374 xenograft GSI_374B Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_374B donor cell line: Panc374 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924982
GPL570
Panc253 xenograft GSI_253A Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_253A donor cell line: Panc253 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924983
GPL570
Panc291 xenograft GSI_291A Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_291A donor cell line: Panc291 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924984
GPL570
Panc374 xenograft GSI_374A Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_374A donor cell line: Panc374 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924985
GPL570
Panc215 xenograft GSI_215A Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_215A donor cell line: Panc215 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924986
GPL570
JH033 xenograft GSI_JH033A Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_JH033A donor cell line: JH033 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924987
GPL570
Panc198 xenograft GSI_198A Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_198A donor cell line: Panc198 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924988
GPL570
Panc420 xenograft GSI_420A Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_420A donor cell line: Panc420 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924989
GPL570
Panc219 xenograft GSI_219B Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_219B donor cell line: Panc219 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924990
GPL570
Panc219 xenograft GSI_219A Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_219A donor cell line: Panc219 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924991
GPL570
Panc215 xenograft GSI_215B Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_215B donor cell line: Panc215 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924992
GPL570
JH033 xenograft GSI_JH033B Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_JH033B donor cell line: JH033 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924993
GPL570
Panc420 xenograft GSI_420B Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_420B donor cell line: Panc420 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924994
GPL570
Panc265 xenograft GSI_265A Sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_265A donor cell line: Panc265 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
GSM924995
GPL570
Panc198 xenograft GSI_198B Non-sensitive to MRK-003 pancreatic ductal adenocarcinoma cell lines sample: GSI_198B donor cell line: Panc198 host: immunocompromised Athymic Nude-Foxn1nu mouse phenotype: Non-sensitive to MRK-003 tissue: Pancreatic ductal adenocarcinoma tumor xenograft We used pancreatic ductal adenocarcinoma cell lines to determine whether pharmacological targeting of the Notch pathway could inhibit pancreatic tumor growth and potentiate gemcitabine sensitivity.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes